Connor, Clark & Lunn Investment Management (CC&L)
CRNX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CRNX Stock Details CRNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,898
Closed -$353K – 1444
2024
Q4 		$353K Sell
6,898
-13,735
-67% -$702K ﹤0.01% 1226
2024
Q3 		$1.05M Buy
20,633
+505
+3% +$25.8K 0.01% 870
2024
Q2 		$902K Buy
+20,128
New +$902K ﹤0.01% 875